Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public
As before, Fosun Pharma achieved a five-star rating, as evaluated by the China CSR Report Rating Expert Committee, for the outstanding performance reported.
- As before, Fosun Pharma achieved a five-star rating, as evaluated by the China CSR Report Rating Expert Committee, for the outstanding performance reported.
- Through its strengths, Fosun Pharma is also helping to solve drug accessibility problems in developing countries and underdeveloped areas.
- Moreover, Fosun Pharma owns industry-leading capability in in&out licensing and internationalization, maximizing the value of each innovative product.
- Furthermore, Fosun Pharma is continually striving for excellence, improving its product quality and medical services, and launched Fosun Pharma Operation Excellence (FOPEX) in 2016.